Targeted Immunomodulation
Targeted Immunomodulation is a precision therapeutic strategy within nanoparticle-based immunotechnology that selectively modulates specific components of the immune system using biologic therapeutics engineered to deliver immunomodulatory signals to defined cellular or molecular targets.
228
Publications
12.2K
Citations
1.7K
Authors
510
Institutions
Publications per year
2017–2026
179
228
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai, Lukasz J. Ochyl, Keith S. Bahjat et al. · Nature Materials · 2016 · 1.1K citations
Life Sciences, Immunology, Oncology +13
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
Chao Wang, Wujin Sun, Grace Wright et al. · Advanced Materials · 2016 · 344 citations
Life Sciences, Immunology, Oncology +17
Luis J. Cruz, Rodney Alexander Rosalia, Jan Willem Kleinovink et al. · Journal of Controlled Release · 2014 · 230 citations
1–5 of 228
1.7K
4
h-index
4
h-index
3
h-index
3
h-index
3
h-index
1–5 of 1.7K
510

Chinese Academy of Sciences
Beijing, China
15 h-index
84 publications
5K citations

Shanghai Jiao Tong University
Shanghai, China
13 h-index
59 publications
2.7K citations
Harvard University
Cambridge, United States
12 h-index
63 publications
4.8K citations

Sichuan University
Chengdu, China
9 h-index
79 publications
4K citations

Sun Yat-sen University
Guangzhou, China
9 h-index
62 publications
3.8K citations
Changchun Institute of Applied Chemistry
Changchun, China
8 h-index
35 publications
2.6K citations
Shandong University
Jinan, China
7 h-index
55 publications
3.2K citations
Jilin University
Changchun, China
6 h-index
21 publications
528 citations
1–8 of 510
20 publications · 1.6K citations
19
h-index
16 publications · 917 citations
14
h-index
12 publications · 283 citations
12
h-index
9 publications · 472 citations
9
h-index
8 publications · 743 citations
9
h-index
1–5